{
    "clinical_study": {
        "@rank": "152960", 
        "arm_group": [
            {
                "arm_group_label": "Resting Trial", 
                "arm_group_type": "No Intervention", 
                "description": "Pancreatic endocrine function will be determined the morning following a day where no exercise is performed"
            }, 
            {
                "arm_group_label": "Exercise Trial", 
                "arm_group_type": "Experimental", 
                "description": "Pancreatic endocrine function will be determined the morning following a day where a 1-hour aerobic exercise is performed at 65% of pre-determined HRmax (maximal heart rate measured during an incremental work-load exercise test to volitional exhaustion)"
            }
        ], 
        "brief_summary": {
            "textblock": "Subjects with type 2 diabetes will be stratified into two-quantiles based on ambient\n      hyperglycemia (fasting glucose and HbA1c) and then the effects of a single aerobic exercise\n      bout (1-hour at 50%VO2max) on pancreatic endocrine function will be determined."
        }, 
        "brief_title": "Acute Exercise and Pancreatic Endocrine Function", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus, Type 2"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Previous diagnosis with type 2 diabetes, or newly detected in our screening\n             procedures\n\n          -  Age 30-70 years\n\n          -  BMI 20-40 kg/m2\n\n        Exclusion Criteria:\n\n          -  Treatment with insulin\n\n          -  Contraindication to exercise as determined by ECG\n\n          -  Pregnancy\n\n          -  Active weight loss in the previous 6 months\n\n          -  Actively engaged in exercise training programs\n\n          -  Evidence of chronic pulmonary, cardiovascular, hepatic, renal, or hematological\n             disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01812590", 
            "org_study_id": "Ex-Panc"
        }, 
        "intervention": {
            "arm_group_label": "Exercise Trial", 
            "intervention_name": "Exercise", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark"
                }, 
                "name": "Rigshospitalet"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Insulin and glucagon secretory responses to intravenous glucose (hyperglycemic clamp 5.4 mmol/l above basal), glucagon-like peptide-1 (0.5 pmol/kg/min), and arginine (5 g injection) will be determined.", 
            "measure": "Pancreatic endocrine function", 
            "safety_issue": "No", 
            "time_frame": "24-hours following a period of rest/exercise"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01812590"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Thomas Solomon", 
            "investigator_title": "Senior Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}